MD772Y - Method for treating precancerous conditions and noninvasive urinary bladder cancer - Google Patents
Method for treating precancerous conditions and noninvasive urinary bladder cancer Download PDFInfo
- Publication number
- MD772Y MD772Y MDS20130156A MDS20130156A MD772Y MD 772 Y MD772 Y MD 772Y MD S20130156 A MDS20130156 A MD S20130156A MD S20130156 A MDS20130156 A MD S20130156A MD 772 Y MD772 Y MD 772Y
- Authority
- MD
- Moldova
- Prior art keywords
- urinary bladder
- bladder cancer
- precancerous conditions
- concentration
- noninvasive
- Prior art date
Links
- 208000006994 Precancerous Conditions Diseases 0.000 title abstract 2
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 title abstract 2
- 201000005112 urinary bladder cancer Diseases 0.000 title abstract 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 abstract 2
- 239000002113 nanodiamond Substances 0.000 abstract 2
- 229930012538 Paclitaxel Natural products 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 239000008169 grapeseed oil Substances 0.000 abstract 1
- 235000012054 meals Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960001592 paclitaxel Drugs 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 1
- 210000003932 urinary bladder Anatomy 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to medicine, particularly to oncology and can be used for treating precancerous conditions and noninvasive urinary bladder cancer.According to the invention, the claimed method consists in that after the complete emptying of the urinary bladder is instilled 150 ml of an ozonated mixture, based on grapeseed oil, containing nanodiamonds of 4…10 nm, in a concentration of 10-9…10-10 g/L, and 0.15 ml of Paclitaxel sol., with ozone concentration of 6000…8000 µg/L, which is administered two times a week, concomitanty, per os, is administered 200 ml of an ozonated emulsion, based on saline, containing 20 ml of 30% sol. of vitamin E and nanodiamonds of 4…10 nm, in a concentration of 10-9…10-10 g/L, with ozone concentration of 6000…10000 µg/L, which is used 3 times a day, 20 minutes before a meal, the course of treatment is 3 months.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20130156A MD772Z (en) | 2013-09-18 | 2013-09-18 | Method for treating precancerous conditions and noninvasive urinary bladder cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20130156A MD772Z (en) | 2013-09-18 | 2013-09-18 | Method for treating precancerous conditions and noninvasive urinary bladder cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD772Y true MD772Y (en) | 2014-05-31 |
| MD772Z MD772Z (en) | 2014-12-31 |
Family
ID=50882640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20130156A MD772Z (en) | 2013-09-18 | 2013-09-18 | Method for treating precancerous conditions and noninvasive urinary bladder cancer |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD772Z (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202100020849A1 (en) * | 2021-08-03 | 2023-02-03 | Moss Pharma S R L | NEW USE OF OZONIZED OIL |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2257912C1 (en) * | 2004-01-13 | 2005-08-10 | Ростовский научно-исследовательский онкологический институт МЗ РФ | Urinary bladder cancer treatment method |
| RU2257219C1 (en) * | 2004-07-16 | 2005-07-27 | Центральный научно-исследовательский рентгено-радиологический институт МЗ РФ (ЦНИРРИ) | Method for treating noninvasive cancer of urinary bladder |
| RU2390341C2 (en) * | 2008-08-08 | 2010-05-27 | Олег Борисович Лоран | Method of conservative treatment of bladder leukoplakia (squamous metaplasia) |
| MD3972C2 (en) * | 2009-03-11 | 2010-07-31 | Ион МЕРЕУЦЭ | Remedy and method for treating precancerous conditions |
| RU2448745C2 (en) * | 2010-05-31 | 2012-04-27 | Олег Феликсович Каган | Method of treating superficial urinary bladder cancer |
| RU2457846C2 (en) * | 2010-07-05 | 2012-08-10 | Александр Анатольевич Зимичев | Method of treatment in case of urinary bladder cancer |
-
2013
- 2013-09-18 MD MDS20130156A patent/MD772Z/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD772Z (en) | 2014-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201590654A1 (en) | COMBINATION OF RASAGILIN AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS, IN PARTICULAR OF HANTINGTON'S DISEASE | |
| ZA202001057B (en) | Inhibiting ubiquitin specific peptidase 30 | |
| MX365835B (en) | Use of akkermansia for treating metabolic disorders. | |
| EA201590655A1 (en) | COMBINATION OF LACHINIMODE AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
| PH12017502375A1 (en) | Method of treating inflammation using natural compounds and/or diet | |
| MX393793B (en) | PHARMACEUTICAL COMPOSITION COMPRISING ASPARAGINASE AND METHIONINASE FOR THE TREATMENT OF CANCER. | |
| UY32739A (en) | COMBINATIONS OF CHEMOTHERAPIC AGENTS AND ANTAGONISTS DLL4 AND ITS USES IN CANCER THERAPY | |
| PE20170392A1 (en) | ADJUNCTIVE THERAPY WITH 25-HYDROXY VITAMIN D | |
| MX2016015437A (en) | COMBINATION THAT INCLUDES A GLUCOCORTICOID AND EDO-S101. | |
| AR125850A2 (en) | TOPICAL PHARMACEUTICAL COMPOSITION, PRODUCTION PROCESS OF THE TOPICAL PHARMACEUTICAL COMPOSITION, USE OF THE TOPICAL PHARMACEUTICAL COMPOSITION AND METHOD OF TOPICAL TREATMENT OF PSORIASIS, ATOPIC DERMATITIS OR CHRONIC ECZEMAS | |
| BR112018076639A2 (en) | combination chemotherapies | |
| MX2016000294A (en) | Pharmaceutical composition for a sustained release of lanreotide. | |
| MX2021003651A (en) | Formulation comprising ozonised oil in the treatment of a tumour. | |
| MX359686B (en) | Metadichol r liquid and gel nanoparticle formulations. | |
| MX2014006559A (en) | Composition for treatment or reduction of symptoms related to premenstrual syndrome (pms), premenstrual disphoric disorder (pmdd), premenopause, menopause or female hormonal disorders in a pharmaceutical composition containing said form, and process for producing said pharmaceutical form and use of said composition. | |
| CO6731081A2 (en) | Method for producing and using a copolymer of sodium carboxymethylcellulose and gosipol | |
| MD772Y (en) | Method for treating precancerous conditions and noninvasive urinary bladder cancer | |
| UY40364A (en) | PHARMACEUTICAL COMPOSITION OF ANTI-CD20 ANTIBODY AND ITS USE | |
| EA201691206A1 (en) | NOOTROPNOE MEANS "PANTOCALCIN" IN LIQUID FORM | |
| MX2018015240A (en) | Compositions comprising timolol and their use in the treatment of rosacea by topical administration. | |
| MD871Y (en) | Method for prophylaxis of radiotherapy or chemotherapy complications in patients with breast cancer | |
| MD783Y (en) | Method for treating chronic atrophic gastritis | |
| MD734Y (en) | Method for treating chronic marginal periodontitis | |
| UA98862U (en) | Method for treating endometrial hyperplasia of women of reproductive age | |
| MX2017000150A (en) | ZEOLITE ACTIVATED AND MICRONIZED, AS A COADYUVANT IN THE TREATMENT OF UREMIA. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG9Y | Short term patent issued | ||
| KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) | ||
| MK4Y | Short term patent expired | ||
| MM4Y | Short-term patent definitely lapsed due to non-payment of fees |